Chemoinformaics analysis of 8-hydroxyhexadecane dioic acid
Molecular Weight | 302.411 | nRot | 15 |
Heavy Atom Molecular Weight | 272.171 | nRig | 2 |
Exact Molecular Weight | 302.209 | nRing | 0 |
Solubility: LogS | -3.199 | nHRing | 0 |
Solubility: LogP | 2.878 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 50.7338 |
nHD | 3 | BPOL | 31.8322 |
QED | 0.402 |
Synth | 2.43 |
Natural Product Likeliness | 0.714 |
NR-PPAR-gamma | 0.973 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.005 |
HIA | 0.238 |
CACO-2 | -5.732 |
MDCK | 0.0000497 |
BBB | 0.019 |
PPB | 0.940993 |
VDSS | 0.36 |
FU | 0.0300521 |
CYP1A2-inh | 0.029 |
CYP1A2-sub | 0.137 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.057 |
CYP2c9-inh | 0.018 |
CYP2c9-sub | 0.985 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.089 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.005 |
CL | 3.074 |
T12 | 0.839 |
hERG | 0.009 |
Ames | 0.004 |
ROA | 0.002 |
SkinSen | 0.318 |
Carcinogencity | 0.096 |
EI | 0.927 |
Respiratory | 0.046 |
NR-Aromatase | 0.026 |
Antiviral | Yes |
Prediction | 0.679992 |